Annovis Bio Publishes Data on New Crystal Form of Lead Alzheimer’s Drug
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the publication of a peer-reviewed article in Biomolecules detailing the pharmacokinetic profile of a newly developed crystal form of buntanetap, its ...
